First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo - Concepedia

Concepedia

Publication | Open Access

First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo

DOI Full Paper Access

98

Citations

22

References

2020

Year

Mingming Wei, Rui Zhao, Yuting Cao, Yujiao Wei, Ming Li, Zhiqiang Dong, Yulin Liu, Hao Ruan, Ying Li, Sheng Cao,

European Journal of Medicinal Chemistry

Medicinal ChemistryPharmaceutical ScienceBiochemistryBioavailable ProdrugNatural SciencesMedicineProteomicsDrug DevelopmentCyclin-dependent Kinases 2/4/6PharmacologyProtein DegradationPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1